Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage, for any covered stock.
TapClick below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
TapClick below to see what's inside, then upgrade to unlock for CTVA and 80,000+ other tickers.
See price against where its own fundamentals say it should trade. The shaded gap is the discount or premium, across five valuation lenses.
TapClick below to see what's inside, then upgrade to unlock for CTVA and 80,000+ other tickers.
See exactly how CTVA's revenue becomes profit: a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for CTVA and 80,000+ other tickers.
Corteva, Inc. operates in the agriculture business. The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers…
INDIANAPOLIS, Oct. 23, 2026 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) today announced its Board of Directors, at its quarterly meeting, has authorized a common stock dividend of $0.05 cents per share, payable December 15, 2026, to the Company's shareholders of record on December 1, 2026. EIDP, Inc. Announces Preferred Stock Dividend The Board of Directors of EIDP, Inc. (formerly known as E.
Corteva, Inc. is rated 'Buy', underpinned by robust growth and profitability levers. CTVA targets +3% annualized top-line expansion (FY26–29), outpacing the global crop protection sector, aided by past and future portfolio enhancements. CTVA is expected to deliver a cumulative 150bps EBITDA margin expansion and +6% EBITDA CAGR over the FY2026-FY2029 period, driven by cost reductions and a shift toward higher-margin biologicals.
TRMB, INGR and DE offer exposure to precision agriculture, food innovation and smarter farming technologies shaping the AgTech landscape.
On October 1, 2026, Corteva Inc. (NYSE:CTVA) completed the spin-off of its seed operating segment into Vylor Inc. (NYSE:VYLR) through a pro rata distribution to holders of record as of the close of business on September 24, 2026. Shareholders received one VYLR share for each CTVA share held.
On October 06, 2026, Corteva Inc (CTVA) shares rose 12.3% to a current price of $13.91. This move comes amid a 52-week range of $9.08 to $14.44, reflecting a ro